ADTX - Company ID 0001726711
Aditxt, Inc. trades as ADTX. In its fiscal 2025 annual report the company posted revenue of $3.19K, down 97.6% from the prior year and net income of -$43.10M. This page tracks Aditxt, Inc. through 548 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 4 fiscal years Aditxt, Inc.'s revenue declined from $105.03K to $3.19K, a compound annual decline rate of 58.2%. Net profit margin compressed from -44148.9% to -1349028.2% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| PRE 14A | - | 2026-05-22 |
| Quarterly report | 10-Q | 2026-05-20 |
| Major company event | 8-K | 2026-05-15 |
| NT 10-Q | - | 2026-05-15 |
| Major company event | 8-K | 2026-05-08 |
| Major company event | 8-K | 2026-05-01 |
| Insider trade | 4 | 2026-04-27 |
| Insider trade | 4 | 2026-04-23 |
The largest companies sharing Aditxt, Inc.'s SEC industry classification (pharmaceutical preparations).
Aditxt, Inc. reported revenue of $3.19K for fiscal year 2025, a decrease of 97.6% year over year.
In its latest fiscal year Aditxt, Inc. reported a net loss of $43.10M.